International Ophthalmic Extravaganza "APAO 2026 Asia-Pacific Academy of Ophthalmology Congress" Concludes Successfully

Over 11,000 Experts from 111 Countries Converge Reaffirming Hong Kong’s Position as a Global Ophthalmic Hub

HONG KONG SAR - Media OutReach Newswire - 13 February 2026 - The four-day "APAO 2026 Asia-Pacific Academy of Ophthalmology (APAO) Congress" successfully concluded last week, marking a significant milestone in the global ophthalmic community. As the largest and most authoritative ophthalmic academic event in the Asia-Pacific region, this year's Congress was hosted in Hong Kong for the fifth time, attracting over 11,000 ophthalmologists, vision scientists, and ophthalmic professionals from 111 countries and regions worldwide. This landmark event not only reaffirmed Hong Kong's distinguished position as a prominent international ophthalmic hub but also fostered profound exchange and extensive collaboration within the global ophthalmic community.

Ophthalmic experts from around the world converge at APAO 2026 Opening Ceremony

Over 1,200 Ophthalmic Sessions: Exploring Clinical Applications and Translational Impact of Cutting-Edge Technology

The Congress was organized by APAO and jointly hosted by the Hong Kong Ophthalmological Society and the College of Ophthalmologists of Hong Kong. Operating under the theme "Eyes on the Future: Innovating Ophthalmology," it presented an impressive agenda featuring over 1,200 specialized ophthalmic symposia and sessions. More than 1,000 distinguished speakers engaged with the 11,000 attendees, collectively exploring the clinical applications and translational potential of state-of-the-art technologies, thereby generating numerous thought-provoking and insightful discussions.

The comprehensive academic agenda spanned 19 ophthalmic subspecialties, offering a rich and diverse array of topics. It delved into not only foundational areas such as cataract, cornea, glaucoma, retina, paediatric ophthalmology, and oculoplastic surgery, among others, but also extended its focus to emerging fields including artificial intelligence, digital innovation, and virtual health. This extensive scope is poised to significantly advance global ophthalmology.

Hong Kong's First Interdisciplinary Myopia Control Expert Research Group Formed to Propose Comprehensive Control Strategies to the Government

During the congress, four major ophthalmic organizations in Hong Kong – Hong Kong Ophthalmological Society, the College of Ophthalmologists of Hong Kong, the Hong Kong Association of Private Eye Surgeons, and the Hong Kong Paediatric Ophthalmology and Strabismus Society – jointly established Hong Kong's first Interdisciplinary Myopia Control Expert Task Force. This group will pioneer the integration of academic research, clinical services, and public education to formulate myopia control strategies for Hong Kong and propose comprehensive recommendations to the HKSAR government. Furthermore, it will promote more holistic, cost-effective, and long-term myopia management solutions by incorporating cutting-edge technologies such as AI, wearable devices, and novel therapies for the public's benefit.

Special Chinese Sessions Accelerated Cross-border and Global Collaboration

To enhance regional cooperation and academic exchange, this year's APAO Congress, in addition to its regular English lectures, has specially introduced Chinese-language sessions. The organisers have invited over a hundred authoritative ophthalmology experts from Chinese Mainland to Hong Kong for in-depth exchanges and participation in discussions in Chinese, aiming to accelerate collaboration between the ophthalmology communities of Chinese Mainland, Hong Kong, and indeed, the world. The congress also attracted 3,000 Chinese Mainland experts and scholars, fully demonstrating the close ties as well as continuous cross-border and international cooperation.

Among these, a public health luncheon themed "China's Myopia Prevention and Control Model" was held. Chinese Mainland experts elaborated to their international ophthalmic peers on how China has successfully established a far-reaching comprehensive myopia prevention and control system through robust public health management, solid scientific research, cutting-edge technologies, and effective policies. It offered valuable experiences for global myopia control efforts.

Cross-border Societies Sign Memorandum of Understanding

New Societies Established to Advance Ophthalmic AI and Stem Cell & Gene Therapy Development

To further strengthen collaboration between Chinese Mainland and Hong Kong in the field of ophthalmology, Chinese Ophthalmological Society, the Hong Kong Ophthalmological Society, and the College of Ophthalmologists of Hong Kong signed a Memorandum of Understanding (MOU) during this congress. The MOU aims to jointly deepen and advance the long-term development of ophthalmology in both regions, charting a new chapter for the field.

Concurrently, the Global Ophthalmic AI and Technology Society (GOATS) and the Asia-Pacific Stem Cell and Gene Therapy Society (APSOCGT) were officially established during the conference. The formation of these two new societies will provide substantial impetus for the advancement of ophthalmic artificial intelligence, technological innovation, stem cell and gene therapy, facilitating their translation from foundational research to clinical application across the Asia-Pacific region and globally.

APAO Congress Held for the Fifth Time in Hong Kong Solidifying the City's Status as an International Ophthalmic Hub

Professor Jason Yam Cheuk-sing, President of APAO 2026 Congress & President of The Hong Kong Ophthalmological Society concluded, "The APAO Congress being held in Hong Kong for the fifth time has underscored the city's internationally recognised excellence in ophthalmology. It not only enhances our clinical capabilities in managing complex cases but also allows this city to showcase its cutting-edge ophthalmic medical technology and research prowess to the world. "

He continued, "On this occasion, I would like to extend my most sincere gratitude to all co-organizers, invited speakers, participants, and sponsoring organizations, especially for the staunch support from the Funding Schemes under the Innovation and Technology Commission, which made APAO 2026 a resounding success. We look forward to Hong Kong securing the hosting rights for APAO again in the future."

This press release is issued by the APAO 2026 Congress.

Hashtag: #APAO2026

The issuer is solely responsible for the content of this announcement.

About the APAO 2026 Congress

The Asia-Pacific Academy of Ophthalmology (APAO) Congress is the largest and most authoritative academic conference for ophthalmology in the Asia-Pacific region. This year's congress (APAO 2026) was held in Hong Kong from 5 to 8 February 2026, in conjunction with the 37th Annual Scientific Meeting of the Hong Kong Ophthalmological Symposium, attracting over 11,000 ophthalmologists, vision scientists, and ophthalmic professionals from around the globe. This prestigious event aims to provide a premier international platform for attendees to exchange professional knowledge, showcase innovative technologies, and foster collaborations to collectively advance the latest global developments in preventing blindness and restoring sight. For more information, please visit https://2026.apaophth.org/.

HONG KONG SAR - Media OutReach Newswire - 13 February 2026 - The four-day "APAO 2026 Asia-Pacific Academy of Ophthalmology (APAO) Congress" successfully concluded last week, marking a significant milestone in the global ophthalmic community. As the largest and most authoritative ophthalmic academic event in the Asia-Pacific region, this year's Congress was hosted in Hong Kong for the fifth time, attracting over 11,000 ophthalmologists, vision scientists, and ophthalmic professionals from 111 countries and regions worldwide. This landmark event not only reaffirmed Hong Kong's distinguished position as a prominent international ophthalmic hub but also fostered profound exchange and extensive collaboration within the global ophthalmic community.

Ophthalmic experts from around the world converge at APAO 2026 Opening Ceremony

Over 1,200 Ophthalmic Sessions: Exploring Clinical Applications and Translational Impact of Cutting-Edge Technology

The Congress was organized by APAO and jointly hosted by the Hong Kong Ophthalmological Society and the College of Ophthalmologists of Hong Kong. Operating under the theme "Eyes on the Future: Innovating Ophthalmology," it presented an impressive agenda featuring over 1,200 specialized ophthalmic symposia and sessions. More than 1,000 distinguished speakers engaged with the 11,000 attendees, collectively exploring the clinical applications and translational potential of state-of-the-art technologies, thereby generating numerous thought-provoking and insightful discussions.

The comprehensive academic agenda spanned 19 ophthalmic subspecialties, offering a rich and diverse array of topics. It delved into not only foundational areas such as cataract, cornea, glaucoma, retina, paediatric ophthalmology, and oculoplastic surgery, among others, but also extended its focus to emerging fields including artificial intelligence, digital innovation, and virtual health. This extensive scope is poised to significantly advance global ophthalmology.

Hong Kong's First Interdisciplinary Myopia Control Expert Research Group Formed to Propose Comprehensive Control Strategies to the Government

During the congress, four major ophthalmic organizations in Hong Kong – Hong Kong Ophthalmological Society, the College of Ophthalmologists of Hong Kong, the Hong Kong Association of Private Eye Surgeons, and the Hong Kong Paediatric Ophthalmology and Strabismus Society – jointly established Hong Kong's first Interdisciplinary Myopia Control Expert Task Force. This group will pioneer the integration of academic research, clinical services, and public education to formulate myopia control strategies for Hong Kong and propose comprehensive recommendations to the HKSAR government. Furthermore, it will promote more holistic, cost-effective, and long-term myopia management solutions by incorporating cutting-edge technologies such as AI, wearable devices, and novel therapies for the public's benefit.

Special Chinese Sessions Accelerated Cross-border and Global Collaboration

To enhance regional cooperation and academic exchange, this year's APAO Congress, in addition to its regular English lectures, has specially introduced Chinese-language sessions. The organisers have invited over a hundred authoritative ophthalmology experts from Chinese Mainland to Hong Kong for in-depth exchanges and participation in discussions in Chinese, aiming to accelerate collaboration between the ophthalmology communities of Chinese Mainland, Hong Kong, and indeed, the world. The congress also attracted 3,000 Chinese Mainland experts and scholars, fully demonstrating the close ties as well as continuous cross-border and international cooperation.

Among these, a public health luncheon themed "China's Myopia Prevention and Control Model" was held. Chinese Mainland experts elaborated to their international ophthalmic peers on how China has successfully established a far-reaching comprehensive myopia prevention and control system through robust public health management, solid scientific research, cutting-edge technologies, and effective policies. It offered valuable experiences for global myopia control efforts.

Cross-border Societies Sign Memorandum of Understanding

New Societies Established to Advance Ophthalmic AI and Stem Cell & Gene Therapy Development

To further strengthen collaboration between Chinese Mainland and Hong Kong in the field of ophthalmology, Chinese Ophthalmological Society, the Hong Kong Ophthalmological Society, and the College of Ophthalmologists of Hong Kong signed a Memorandum of Understanding (MOU) during this congress. The MOU aims to jointly deepen and advance the long-term development of ophthalmology in both regions, charting a new chapter for the field.

Concurrently, the Global Ophthalmic AI and Technology Society (GOATS) and the Asia-Pacific Stem Cell and Gene Therapy Society (APSOCGT) were officially established during the conference. The formation of these two new societies will provide substantial impetus for the advancement of ophthalmic artificial intelligence, technological innovation, stem cell and gene therapy, facilitating their translation from foundational research to clinical application across the Asia-Pacific region and globally.

APAO Congress Held for the Fifth Time in Hong Kong Solidifying the City's Status as an International Ophthalmic Hub

Professor Jason Yam Cheuk-sing, President of APAO 2026 Congress & President of The Hong Kong Ophthalmological Society concluded, "The APAO Congress being held in Hong Kong for the fifth time has underscored the city's internationally recognised excellence in ophthalmology. It not only enhances our clinical capabilities in managing complex cases but also allows this city to showcase its cutting-edge ophthalmic medical technology and research prowess to the world. "

He continued, "On this occasion, I would like to extend my most sincere gratitude to all co-organizers, invited speakers, participants, and sponsoring organizations, especially for the staunch support from the Funding Schemes under the Innovation and Technology Commission, which made APAO 2026 a resounding success. We look forward to Hong Kong securing the hosting rights for APAO again in the future."

This press release is issued by the APAO 2026 Congress.

Hashtag: #APAO2026

The issuer is solely responsible for the content of this announcement.

About the APAO 2026 Congress

The Asia-Pacific Academy of Ophthalmology (APAO) Congress is the largest and most authoritative academic conference for ophthalmology in the Asia-Pacific region. This year's congress (APAO 2026) was held in Hong Kong from 5 to 8 February 2026, in conjunction with the 37th Annual Scientific Meeting of the Hong Kong Ophthalmological Symposium, attracting over 11,000 ophthalmologists, vision scientists, and ophthalmic professionals from around the globe. This prestigious event aims to provide a premier international platform for attendees to exchange professional knowledge, showcase innovative technologies, and foster collaborations to collectively advance the latest global developments in preventing blindness and restoring sight. For more information, please visit https://2026.apaophth.org/.

** The press release content is from Media OutReach Newswire. Bastille Post is not involved in its creation. **

Revenue Up 35.4% Year-on-Year API Token Call Volume Surges Nearly 6 Times

HONG KONG SAR - Media OutReach Newswire - 22 May 2026 - Phancy Group Co., Ltd. ("Phancy" or "The Company", stock code: 6682.HK), a leading general artificial intelligence company, today announced its unaudited consolidated results for the first quarter ended 31 March 2026.

During the period, Phancy achieved revenue of approximately RMB1.458 billion, representing a 35.4% year-on-year increase. Gross profit margin remained at 35.1%. Phancy leveraged its deep expertise in full-stack AI cloud services, to capitalize on the accelerating adoption of localized computing power and strong enterprise demand for AI solutions. The Company achieved robust growth in its core businesses, accelerated product innovation, and secured several major partnerships, sustaining strong operational momentum.

2026 First Quarter Business Highlights:

Unified Enterprise AI Platform Drives Explosive Core Business Growth

Global computing resources remain constrained, while demand for both private enterprise AI deployments and API-based model calls continues to grow rapidly. Phancy's enterprise-grade AI platform is built on a unified core architecture that seamlessly supports both API calling scenarios and dedicated private deployments. This significantly boosts AI application efficiency and resource utilization. Supported by a mature computing power supply chain developed over many years, Phancy's deployable computing power resources have increased by over 200%. This enables the Company to effectively meet surging Token demand and consistently deliver stable, high-quality AI services to its customers.

In the first quarter of 2026, API Token call volume surged nearly 6 times compared to the same period in 2025, and already accounted for nearly 40% of the full-year 2025 total. Meanwhile, the Agentic AI business expanded rapidly, with deepening commercial adoption. Orders on hand grew nearly 100% compared to the end of 2025, emerging as a major growth driver for the Company.

AI Technology Iteration Accelerates, Commercialization Beats Expectations

Building on its continued push into digital employee applications and AI empowerment across business units, Phancy has significantly shortened the product development cycle from R&D to commercialization, enhancing overall operational efficiency and customer satisfaction.

As of mid-May 2026, ModelHub XC has completed adaptation and optimization for over 70,000 AI models on domestic chips, achieving more than 70% of its full-year target - well ahead of schedule.

In May, Phancy launched PhanthyMovie, a professional-grade AI video generation platform designed to enhance creativity, control, and stability in video production, enabling standardized and large-scale content creation for the industry.

Leveraging its advanced technology and proven execution capabilities, PhanthyMovie achieved rapid commercial traction. Just days after launch, the Company entered into a strategic cooperation agreement with Huanxi Media, covering approximately US$200 million in AI Token usage. The two parties will also collaborate on the development of a next-generation AI-powered film and television content production platform, further strengthening Phancy's position in the AI-driven cultural and creative sector.

Core Products Align Closely with Policy Trends, Strengthening Compute-Model Integration

Since May 2026, China's AI sector has seen a series of positive policy developments focused on computing infrastructure, data element circulation, and open-source compliance governance. Phancy's core products, including HAMi vGPU and ModelHub XC, are well-aligned with national policy directions and mainstream industry trends.

In terms of computing resource allocation, policies emphasize cross-regional collaboration and broader access to computing power. Phancy's HAMi vGPU offers unified scheduling and fine-grained resource partitioning, effectively improving utilization rates, optimizing data center energy efficiency, and supporting unified management across multiple chips to boost single-card efficiency.

In data and model governance, the government continues to promote high-quality dataset development and compliance management. ModelHub XC supports multi-model adaptation and optimization, incorporates data traceability and security certification features to help enterprises reduce compliance risks, and uses the EngineX engine for batch adaptation of domestic chips and models. This significantly improves compatibility while enhancing Token output efficiency through targeted model tuning.

Through deep integration of its computing and model layers, Phancy has built a comprehensive "Compute–Model" integrated solution. This addresses key industry needs such as efficient computing utilization, secure data supply, enterprise compliance, and domestic substitution, while strengthening its technological moat. The Company is well positioned to capture policy dividends and industry opportunities, supporting enterprises in their digital and intelligent transformation.

Hashtag: #PhancyGroup

The issuer is solely responsible for the content of this announcement.

About Phancy Group

Phancy Group (6682.HK) is a leading full-stack AI cloud services platform, providing comprehensive solutions for the AI 2.0 era. Our offerings include SageAIOS, HAMi vGPU and ModelHub XC, delivering efficient and scalable AI infrastructure with end-to-end capabilities. We provide a complete solution from heterogeneous compute resource management and optimization to the deployment of intelligent agent models. These solutions empower digital transformation across a wide range of industries, supporting our vision of building a large-scale and efficient "Token Factory."

Guided by the mission of "AI for Everyone" and positioned as the "Navigator of AI," Phancy Group is committed to becoming a global leader in Artificial General Intelligence.

HONG KONG SAR - Media OutReach Newswire - 22 May 2026 - Phancy Group Co., Ltd. ("Phancy" or "The Company", stock code: 6682.HK), a leading general artificial intelligence company, today announced its unaudited consolidated results for the first quarter ended 31 March 2026.

During the period, Phancy achieved revenue of approximately RMB1.458 billion, representing a 35.4% year-on-year increase. Gross profit margin remained at 35.1%. Phancy leveraged its deep expertise in full-stack AI cloud services, to capitalize on the accelerating adoption of localized computing power and strong enterprise demand for AI solutions. The Company achieved robust growth in its core businesses, accelerated product innovation, and secured several major partnerships, sustaining strong operational momentum.

2026 First Quarter Business Highlights:

Unified Enterprise AI Platform Drives Explosive Core Business Growth

Global computing resources remain constrained, while demand for both private enterprise AI deployments and API-based model calls continues to grow rapidly. Phancy's enterprise-grade AI platform is built on a unified core architecture that seamlessly supports both API calling scenarios and dedicated private deployments. This significantly boosts AI application efficiency and resource utilization. Supported by a mature computing power supply chain developed over many years, Phancy's deployable computing power resources have increased by over 200%. This enables the Company to effectively meet surging Token demand and consistently deliver stable, high-quality AI services to its customers.

In the first quarter of 2026, API Token call volume surged nearly 6 times compared to the same period in 2025, and already accounted for nearly 40% of the full-year 2025 total. Meanwhile, the Agentic AI business expanded rapidly, with deepening commercial adoption. Orders on hand grew nearly 100% compared to the end of 2025, emerging as a major growth driver for the Company.

AI Technology Iteration Accelerates, Commercialization Beats Expectations

Building on its continued push into digital employee applications and AI empowerment across business units, Phancy has significantly shortened the product development cycle from R&D to commercialization, enhancing overall operational efficiency and customer satisfaction.

As of mid-May 2026, ModelHub XC has completed adaptation and optimization for over 70,000 AI models on domestic chips, achieving more than 70% of its full-year target - well ahead of schedule.

In May, Phancy launched PhanthyMovie, a professional-grade AI video generation platform designed to enhance creativity, control, and stability in video production, enabling standardized and large-scale content creation for the industry.

Leveraging its advanced technology and proven execution capabilities, PhanthyMovie achieved rapid commercial traction. Just days after launch, the Company entered into a strategic cooperation agreement with Huanxi Media, covering approximately US$200 million in AI Token usage. The two parties will also collaborate on the development of a next-generation AI-powered film and television content production platform, further strengthening Phancy's position in the AI-driven cultural and creative sector.

Core Products Align Closely with Policy Trends, Strengthening Compute-Model Integration

Since May 2026, China's AI sector has seen a series of positive policy developments focused on computing infrastructure, data element circulation, and open-source compliance governance. Phancy's core products, including HAMi vGPU and ModelHub XC, are well-aligned with national policy directions and mainstream industry trends.

In terms of computing resource allocation, policies emphasize cross-regional collaboration and broader access to computing power. Phancy's HAMi vGPU offers unified scheduling and fine-grained resource partitioning, effectively improving utilization rates, optimizing data center energy efficiency, and supporting unified management across multiple chips to boost single-card efficiency.

In data and model governance, the government continues to promote high-quality dataset development and compliance management. ModelHub XC supports multi-model adaptation and optimization, incorporates data traceability and security certification features to help enterprises reduce compliance risks, and uses the EngineX engine for batch adaptation of domestic chips and models. This significantly improves compatibility while enhancing Token output efficiency through targeted model tuning.

Through deep integration of its computing and model layers, Phancy has built a comprehensive "Compute–Model" integrated solution. This addresses key industry needs such as efficient computing utilization, secure data supply, enterprise compliance, and domestic substitution, while strengthening its technological moat. The Company is well positioned to capture policy dividends and industry opportunities, supporting enterprises in their digital and intelligent transformation.

Hashtag: #PhancyGroup

The issuer is solely responsible for the content of this announcement.

About Phancy Group

Phancy Group (6682.HK) is a leading full-stack AI cloud services platform, providing comprehensive solutions for the AI 2.0 era. Our offerings include SageAIOS, HAMi vGPU and ModelHub XC, delivering efficient and scalable AI infrastructure with end-to-end capabilities. We provide a complete solution from heterogeneous compute resource management and optimization to the deployment of intelligent agent models. These solutions empower digital transformation across a wide range of industries, supporting our vision of building a large-scale and efficient "Token Factory."

Guided by the mission of "AI for Everyone" and positioned as the "Navigator of AI," Phancy Group is committed to becoming a global leader in Artificial General Intelligence.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **